Patient Power®
Get Email Alerts!
Health Topics
Multiple Sclerosis (MS) Health Center
Health Center Home Audio Programs Videos
Search by Keyword:
Search by Health Topic:
View all Health Topics >
Spring Survey 2012 Results

The Latest News in Treatment for Multiple Sclerosis

Recorded on 5/15/2009
AUDIO
Listen NowListen to Program Download Audio MP3
SHARE
Share this Program
SPONSOR
  • Center Neuroscience Orthopaedic & Spine

PROGRAM DETAILS:

BREAKING NEWS: A new drug, Ampyra (generic name dalfampridine, formerly known as fampridine), has been approved as the first oral drug in multiple sclerosis. It's too early to tell what this will mean for most MS patients, but it is a long awaited step. After the annual meeting of neurologists in 2009, we interviewed an MS specialist about oral therapy.

Hear a community neurologist's perspective on what the latest studies mean for living better with Multiple Sclerosis (MS). Dr. Christopher Hughes, a respected neurologist from North Sioux City, S.D. explains new data that shows continued long-term effectiveness for the well established, injectable, disease-modifying medicines. He explains concerning safety data on two oral medicines for MS and encouraging information about a third oral medicine that could be used in combination therapy. Dr. Hughes stresses the importance of patients staying on treatment plans that are working for them now.

Get Email Updates:

Get updated automatically when new content about Multiple Sclerosis has been posted.
Privacy Policy
Multiple SclerosisMore Health Topics
EXPERTS & GUESTS:
Christopher A. Hughes, Ph.D., M.D.
Neurologist, Center Neuroscience Orthopaedic & Spine
Dr. Christopher Hughes received his medical degree from the University of Illinois at Chicago and completed his neurology residency at Rush Presbyterian St. Lukes Medical Center in Chicago. He is board certified in Neurology. He is currently a neurologist at the Center Neuroscience Orthopaedic & Spine in North Sioux City, South Dakota. more >

RELATED LINKS: